Avalo Therapeutics Inc.

NASDAQ: AVTX · Real-Time Price · USD
9.05
0.10 (1.12%)
At close: Aug 15, 2025, 3:59 PM
9.24
2.10%
After-hours: Aug 15, 2025, 07:50 PM EDT

Avalo Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.72 -0.08 -1.14 -2.1
PEG Ratio
0.02 0.00 0.02 0.27
PS Ratio
136.95 1.31 2.63 32.83
PB Ratio
0.45 0.35 -4.34 7.68
P/FCF Ratio
-1.23 -0.08 -1.77 -2.5
P/OCF Ratio
-1.23 -0.08 -1.77 -2.5
OCF/S Ratio
-111.24 -15.95 -1.48 -13.13
Debt / Equity Ratio
0.00 0.07 -1.78 1.42
Quick Ratio
19.96 1.82 0.74 3.11
Current Ratio
19.96 1.82 0.74 3.11
Asset Turnover
0.00 0.09 0.54 0.07
Interest Coverage
n/a -8 -8.98 -34.35
Return on Equity
-0.26 -4.32 3.82 -3.65
Return on Assets
-0.23 -1.5 -1.25 -1.05
Return on Invested Capital
-0.48 -1.62 -2.11 -1.35
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.83 0.33 0.81 0.72
Net Profit Margin
-79.66 -16.4 -2.31 -15.63
Pretax Profit Margin
-79.4 -16.39 -2.31 -15.66
Operating Profit Margin
-155.36 -14.22 -2.07 -15.22
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-154.97 -12.1 -2.07 -14.91